HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)

HLB Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2019	FY 2018	FY 2017
Period Ending	Apr 9, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Market Capitalization	244,617	225,238	338,419	75,194	58,507	80,206
Market Cap Growth	-29.47%	-33.44%	350.06%	28.52%	-27.05%	-
Enterprise Value	243,164	215,584	336,454	77,595	-	-
Last Close Price	17420.00	16040.00	24100.00	5430.00	4225.00	6420.00
PE Ratio	124.43	49.27	167.55	159.09	-	-
PS Ratio	1.19	1.10	2.47	2.08	2.85	5.16
PB Ratio	1.95	1.80	2.91	4.20	3.44	4.77
P/TBV Ratio	2.02	1.86	3.02	4.31	3.50	4.83
P/FCF Ratio	-	-	83.73	-	-	-
P/OCF Ratio	429.92	395.87	49.47	55.56	-	-
EV/Sales Ratio	1.18	1.05	2.45	2.15	-	-
EV/EBITDA Ratio	32.42	41.65	51.26	25.19	-	-
EV/EBIT Ratio	71.77	202.65	228.26	53.85	-	-
EV/FCF Ratio	-36.61	-	83.24	-	-	-
Debt / Equity Ratio	0.17	0.17	0.14	0.74	0.45	0.89
Debt / EBITDA Ratio	4.00	4.00	2.45	4.28	-	-
Debt / FCF Ratio	-	-	3.97	-	-	-
Net Debt / Equity Ratio	-0.01	-0.01	-0.05	-0.11	-0.08	0.21
Net Debt / EBITDA Ratio	-0.28	-0.28	-0.90	-0.64	0.30	-1.27
Net Debt / FCF Ratio	0.22	0.22	-1.47	44.86	0.49	-1.18
Asset Turnover	1.25	1.25	-	0.88	0.54	-
Inventory Turnover	3.79	3.79	-	3.27	3.13	-
Quick Ratio	1.17	1.17	1.02	1.01	0.94	1.01
Current Ratio	1.94	1.94	1.64	1.26	1.31	1.31
Return on Equity (ROE)	3.79%	3.79%	-	2.71%	-41.77%	-
Return on Assets (ROA)	0.40%	0.40%	-	2.19%	-9.55%	-
Return on Invested Capital (ROIC)	0.83%	0.83%	2.33%	9.14%	-32.41%	-18.92%
Return on Capital Employed (ROCE)	0.80%	0.80%	1.20%	6.30%	-28.80%	-17.40%
Earnings Yield	1.87%	2.03%	0.60%	0.63%	-12.07%	-6.79%
FCF Yield	-2.72%	-2.95%	1.19%	-0.06%	-4.91%	-3.77%
Buyback Yield / Dilution	-135.81%	-1.86%	-131.51%	-2.30%	-13.08%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.